Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 737 - 744 of 11617 results
Important Issues in Purchasing and Resolving Distressed Real Estate Debt
January 5, 2024| News
The Future of Federal Arbitration Act Practice After ‘Badgerow’
January 5, 2024| News
Year in Review: The Most Popular IP Posts of 2023
January 4, 2024| Blog| Viewpoint
Think Twice Before Hitting 'Send' After 9 at Night
January 4, 2024| News
Enel Faces Huge Bill To Dismantle 84-Turbine Wind Farm As US Judge Backs Tribal Nation
January 4, 2024| News
10th Circuit Rejects District Court’s Maui Application, Citing Additional Factors
January 4, 2024| News
White House Launches Initiative on Women’s Health Research
January 3, 2024| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.